PHILADELPHIA, Dec. 18 /PRNewswire-FirstCall/ -- CDI Corp. (NYSE: CDI) announced today that the Life Sciences division of its CDI Engineering Solutions business has been awarded a contract from CJ CheilJedang Corporation to provide engineering design for a major new grassroots pharmaceutical manufacturing complex to be located in Osong, Korea. The complex for CJ Pharmaceuticals will be the manufacturing center for global distribution of oral solid and sterile liquid drug products.
"We are pleased with the confidence shown in CDI by CJ CheilJedang Corporation," said Robert Giorgio, President of CDI Engineering Solutions. "Our past experience in designing pharmaceutical and biotech facilities in Korea and our ability to assist clients in gaining both FDA and EU regulatory approvals for their facilities played an important role in the awarding of this project. We are excited about the opportunity to work with a firm like CJ CheilJedang Corporation who are not only leaders in the development of pharmaceutical products but who are also committed to a true partnership with their suppliers."
Engineering work for the multi-year project will be in both Korea and in CDI-Life Sciences' Philadelphia-based engineering center.
Headquartered in Philadelphia, CDI Corp. (NYSE: CDI) is a leading provider of engineering and information technology outsourcing solutions and professional staffing. Its operating units include CDI Engineering Solutions, CDI IT Solutions, CDI AndersElite Limited and Management Recruiters International, Inc. Visit CDI at http://www.cdicorp.com.
|SOURCE CDI Corp.|
Copyright©2007 PR Newswire.
All rights reserved